Access to Information Requests Completed - June 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of June 2011

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2008-01056	All records dealing with health and safety inspections or reports done on any school or any other educational facility in Attawapiskat, Ontario. (Jan 1, 2005 to Dec 31, 2008).	Disclosed in part	450
A-2009-00294	Information regarding Heather Crowe's involvement with Health Canada's Tobacco Control Program. (Jan 1, 2002 to Dec 31, 2002).	Disclosed in part	809
A-2009-01389	Documents regarding Caffeinated Energy Drinks and the proposed Abbreviated Labelling Standard for Caffeinated Energy Drinks.	Disclosed in part	233
A-2010-00176	Documents regarding energy drinks in food directorate. (Jan 1, 2010 to May 10, 2010).	Disclosed in part	667
A-2010-00560	Emails and memos between various Health Canada divisions on benzodiazepine (BZP). (Jan 16, 2009 to Feb 13, 2009).	Disclosed in part	80
A-2010-00614	All studies or investigations funded directly or indirectly or of which Health Canada was a partner dealing with environmental concerns with mercury in the Wabigoon-English-Winnipeg River system in Northwestern Ontario.	Disclosed in part	1,096
A-2010-00702	Information regarding the medical device Aloclair Gel, Licence No. 69156 by Sinclair Pharma S.R.L.	All disclosed	21
A-2010-00837	Information regarding the product Lyprinin, NPN 1900463.	Disclosed in part	116
A-2010-00843	Information regarding the product Risedronate, DIN 02347474 by Pro Doc Limitée.	Disclosed in part	98
A-2010-00845	Information regarding the product Riva-risedronate, DIN 02341077 by Laboratoire Riva Inc.	All disclosed	93
A-2010-00857	All documents related to the resignations of members of the board of directors at Assisted Human Reproduction Canada. (Mar 1, 2010 to Nov 15, 2010).	Disclosed in part	22
A-2010-00859	Question Period notes September 15-21, 2010: National Home Care Strategy Natural Health Products - Energy Drinks Palliative Care National Strategy Supply of Medical Isotopes Euthanasia and Assisted Suicide Consumer Safety - Cell Phones, Cell Phone Towers and WiFi Systems Contraband Tobacco Products Genetically Modified Salmon	Disclosed in part	37
A-2010-00890	Information relating to an inspection at the premises of Nu-Quest Distribution Inc on September 23, 2010.	Disclosed in part	19
A-2010-01006	Information regarding the NPN 80019004 by Market America Inc.	Disclosed in part	72
A-2010-01008	Information regarding the product Della-Pretech Plus, DIN 00878766.	Disclosed in part	10
A-2010-01009	Information regarding the product Theratec Pre & Post Sanitizing Teat Dip, DIN 00611980.	Disclosed in part	8
A-2010-01043	All documents regarding CBC & CBC coverage of tobacco, industry, policies, lobbying, warning labels, quit line, contraband and Minister Aglukkaq. (Nov 29, 2010 to Dec 17, 2010).	Disclosed in part	150
A-2010-01119	Reports or studies that reveal whether or not Canada's Food Guide took Canadian agriculture into account for the province of Ontario from 2005 to 2010.	All disclosed	2
A-2010-01158	TPD inspection reports since 2007 of the following drug manufacturer site: Draxis Speciality Pharmaceuticals Inc. 16751 Route Transcannadienne Kirkland, QC, Canada, H9H 4J4	Disclosed in part	8
A-2010-01223	All 'public opinion research' and 'international studies' regarding Health Canada's January 24, 2011 press release entitled " Health Canada and Public Safety Canada address the Government's efforts on health hazards associated with tobacco use".	All disclosed	3,208
A-2010-01250	Information regarding the product Now Acerola 4 : 1 Extract Powder, NPN 80022199 by Now Foods.	All disclosed	88
A-2010-01272	Information regarding the 'Quality System Framework for the Inspectorate Quality Management System'.	All disclosed	85
A-2010-01291	Provide the contract documents and amendments for contract 4500211390.	Disclosed in part	37
A-2010-01292	AERs for the product Kaletra. Report numbers: 000343359 and 000345786.	Disclosed in part	10
A-2010-01294	Documents for contract 4500235817 reference number.	Disclosed in part	35
A-2010-01311	AERs for the product CanesOral. Report numbers: 000348364, 000347051, 000347438, 000348361, 000348363, 000348998 and 000349470.	Disclosed in part	23
A-2010-01316	Information regarding all correspondence and/or Air Bills between Airborne Energy and North Peace Tribal Council. (Jan 01, 2010 to Dec 10, 2010).	Disclosed in part	734
A-2010-01350	Copies of any memorandum email from Health Canada representatives with respect to any adverse reactions or any adverse reaction reports in connection with TERBINAFINE. (Jan 1, 2009 to Feb 23, 2011).	Disclosed in part	3
A-2010-01354	Copies of any memorandum, email from Health Canada representatives with respect to any adverse reactions or any adverse reaction reports in connection with PATOXETINE. (Jan 1, 2009 to Feb 23, 2011).	Disclosed in part	222
A-2010-01464	All internal documents related to a 2009 submission by Hema-Quebec to modify its donor deferral policy, or donor exclusion measures, which permanently defers men who have had sex with other men since 1977 from donating blood. (Jan 1, 2009 to Mar 10, 2011).	All disclosed	16
A-2010-01480	Documents regarding a study on Controlled Human Exposures to Concentrated Ambient Particles: Ultrafine Particle and VOC Health Effects of Composition on Fine Particle Health Effects.	Disclosed in part	4
A-2010-01481	Records showing expenses / costs for the Healthy Canadians > Healthy Living Initiatives > Kids' Health and Safety website of the costs incurred for the period ending March 31, 2011.	All disclosed	1
A-2010-01486	Copies of receipts, invoices and guest lists detailing travel and hospitality expenses including meals claimed by Health Canada Minister Leona Aglukkaq (and all Ministers' office personnel). (Dec 1, 2009 to Mar 15, 2011).	Disclosed in part	300
A-2010-01533	AERs for the product Aspirin. Report numbers: 000358685 and 000358781.	Disclosed in part	9
A-2010-01550	AER for the product CIPRO. Report number: 000357455.	Disclosed in part	7
A-2010-01570	Beginning on May 27, 2010, all records related to the amendment of Policy 19 (POL-0019) and resulting in the implementation in July 2010 of GUI-0084 and POL-0060.	Disclosed in part	59
A-2010-01581	All emails to/from Paul Glover about tobacco health warning labels. (Jul 1, 2010 to Oct 31, 2010).	All disclosed	2
A-2010-01595	The job description for the Director of the Assets and Data Management Division in the Material and Assets Management Directorate within the Chief Financial Officer Branch as per June 2010.	All disclosed	8
A-2011-00003	AERs for the product Norvir. Report numbers: 000349016 and 000349497.	Disclosed in part	10
A-2011-00004	AER for the product Mavik. Report number: 000347463.	Disclosed in part	6
A-2011-00010	Any documentation provided from Indian and Northern Affairs Canada (INAC) to Health Canada related to the First Nations and Inuit Transfer Payments. (Apr 1, 2009 to Mar 31, 2011).	Disclosed in part	26
A-2011-00025	Question Period notes December 1-2, 2010: Donating Organs in Canada (HPFB) Canada Health Act - Queue Jumping in Quebec (SPB) Proposed Canada Consumer Product Safety Act (HPFB)	All disclosed	10
A-2011-00032	Health Canada's review of the risk of Nephrogenic Systemic Fibrosis (NSF) associated with the use of gadolinium-based contrast agents, in particular, Primovist.	All disclosed	28
A-2011-00036	AER. Report numbers: 000142166.	Disclosed in part	4
A-2011-00037	AER. Report numbers: 000176435.	Disclosed in part	4
A-2011-00040	AER. Report numbers: 000309966.	All disclosed	5
A-2011-00041	AER. Report numbers: 000316009.	Disclosed in part	13
A-2011-00042	AER. Report numbers: 000328164.	All disclosed	9
A-2011-00043	A listing of the Access to Information requests submitted to Health Canada for the period of October 1, 2010 to March 31, 2011.	Disclosed in part	180
A-2011-00054	AERs for the product Synthroid. Report numbers: 000347000 and 000352395.	Disclosed in part	3
A-2011-00056	Product monograph for MIDAZOLAM INJECTION, DIN 02240286 by SANDOZ CANADA INCORPORATED.	All disclosed	39
A-2011-00065	Request to view the spreadsheet containing the status of all compounds, substances, chemicals, plants or animals that have been reviewed by the Office of Controlled Substance.	All disclosed	224
A-2011-00075	All documents produced, not released publicly, on weight-loss products. (Apr 13, 2010 to Apr 12, 2011).	Disclosed in part	17
A-2011-00076	Information on the purchase of Autonomy software.	Disclosed in part	21
A-2011-00119	A listing only for Supply Arrangements under Temporary Help Services in the National Capital Region. From April 2010 until October 2010.	All disclosed	8
A-2011-00136	AER for the product WinRho SDF. Report number: 000350484.	Disclosed in part	3
A-2011-00147	All NPN numbers issued up until April 1, 2011.	All disclosed	117
A-2011-00149	All legislation, act or regulation that allows the Government of Canada, through the Government of British Columbia, to charge a fee or make any levy for the reason of providing of healthcare services to the individual citizens of Canada.	Disclosed in part	1
A-2011-00155	Number of SAP releases for Afatinib. From Jan 1, 2009 to May 3, 2011.	All disclosed	1
A-2011-00156	Number of SAP releases for the following drugs for the month of April 2011: Dacogen (Decitabine) Fotolyn (Pralatrexate) Prochymal (Remestemcel-L) Targretin (Bexaretene) Treanda (Bendamustine) Carfilzomib Cabazitaxel (Jevtana) Halaven (Eribulin Mesylate) Prochymal	All disclosed	1
A-2011-00157	Nutritional information written on the Nutrition Facts labels on food packaging. The names of all chemical additives that may be found in each of the following ingredients: spices, natural flavours and artificial flavours.	No records exist	0
A-2011-00170	All test reports, certificates of compliance, and all other compliance related documents for the following lighters manufactured by parent company, Zhuoye Lighter Manufacturing Company. (Jan 1, 2000 to May 4, 2011).	No records exist	0
A-2011-00194	All Callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of April 2011.	Disclosed in part	103
A-2011-00196	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region during April 2011.	All disclosed	5
A-2011-00197	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of April 2011.	All disclosed	4
A-2011-00207	The names of manufacturers with licenses authorizing them to manufacture tobacco products and/or cigarettes and whether or not these can be found on First Nations reserves.	No records exist	0
A-2011-00218	Information detailing the number of people licensed by Health Canada to grow medical marijuana within the city of Prince George, British Columbia as of May 9, 2011.	All disclosed	1
A-2011-00221	Copy of the risk management guidelines on and incident reports related to photocopiers. (May 20, 2008 to May 19, 2011).	No records exist	0
A-2011-00232	Information regarding the product Enteric Coated Daily Low Dose ASA 81mg, DIN 02363127 by Vita Health Products Inc.	All exempted	0
A-2011-00233	Information regarding the product Advil Cold & Sinus PE, DIN 02365782 by Pfizer Consumer Healthcare, a division of Pfizer Canada Inc.	All exempted	0
A-2011-00243	AER for the product Isoflurane. Report number: 000358927.	Disclosed in part	6
A-2011-00244	AER for the product Biaxin. Report number: 000358563.	Disclosed in part	1
A-2011-00246	All documents relating to consideration of requiring Health Canada Infoway Inc., to disclose the total annual compensation for each officer director and employee whose compensation exceeds $100,000 per year.	No records exist	0
A-2011-00254	A listing of the Access to Information requests submitted to Health Canada for the period of April 2011.	Disclosed in part	9
A-2011-00255	A listing of the Access to Information requests submitted to Health Canada for the period of March 2011.	Disclosed in part	12
A-2011-00258	Number of SAP releases for the following drug for the year 2010: Dacogen (Decitabine)	All disclosed	1
A-2011-00264	AERs. Report number: 000339444 and 000343455.	Disclosed in part	3
A-2011-00267	Number of SAP releases for the following drug for the month of May 2011: Dacogen (Decitabine).	All disclosed	1
A-2011-00268	Number of SAP releases for the following drug for the month of May 2011: Folotyn (Pralatrexate)	No records exist	0
A-2011-00269	Number of SAP releases for the following drug for the month of May 2011: Prochymal (Remestemcel-L)	No records exist	0
A-2011-00270	Number of SAP releases for the following drug for the month of May 2011: Targretin (Bexaretene)	No records exist	0
A-2011-00271	Number of SAP releases for the following drug for the month of May 2011: Treanda (Bendamustine)	All disclosed	1
A-2011-00272	Number of SAP releases for the following drug for the month of May 2011: Carfilzomib	No records exist	0
A-2011-00273	Number of SAP releases for the following drug for the month of May 2011: Cabazitaxel (Jevtana)	No records exist	0
A-2011-00274	Number of SAP releases for the following drug for the month of May 2011: Halaven (Eribulin Mesylate)	No records exist	0
A-2011-00275	Number of SAP releases for the following drug for the month of May 2011: Zolinza	No records exist	0
A-2011-00276	Number of SAP releases for the following drug for the month of May 2011: Belinostat	No records exist	0
A-2011-00288	All documents about results of consultation on Discretionary Food Fortification with the Department of Agriculture.	No records exist	0
A-2011-00296	All documentation relating to Vivo Cosmetics between 2006 to 2011.	No records exist	0
A-2011-00308	Correspondence between the governments of Canada and the United Kingdom relating to plain packaging. (Jan 1, 2008 to Jun 6, 2011).	No records exist	0
A-2011-00309	Financial or economic modelling of the effectiveness of plain packaging in reducing smoking prevalence, and documents containing or referring to that modelling. (Jan 1, 1998 to Jun 6, 2011).	No records exist	0
A-2011-00310	Financial or economic modelling of the likely or assumed costs and/or benefits to the Canadian government of implementing plain packaging, and documents containing or referring to that modelling. (Jan 1, 1998 to Jun 6, 2011).	No records exist	0
A-2011-00313	All documents pertaining to the recommendation by Dr. Yvette Bonvalot, (Jan 1, 1998 to Dec 31, 2001), that an epidemiological study be carried out on the military and civilian populations at Canadian Forces Base Valcartier concerning exposure to TCE and other pollutants on the base property and/or water supply.	No records exist	0
A-2011-00314	Documents regarding design or development of the Joint Review Panel, as defined in the Agreement between the National Energy Board and the Minister of the Environment Concerning the Joint Review of the Northern Gateway Pipeline Project, that refers to aboriginal consultation and accommodation. (Jan 1, 2004 to Jun 8, 2011).	No records exist	0
A-2011-00347	All documents relating to the Mobile Study - A study of Bonviva (lbandrondle) Regimens in woman with Post-menopausal Osteoporosis dated January 1, 2003 or earlier.	No records exist	0